FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vincent Calvez

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Patricia Recordon-Pinson; C Soulie; Pantxika Bellecave; Vincent Calvez; Diane Descamps; H Fleury; P R Harrigan; J Izopet; Anne-Geneviève Marcelin; Bernard Masquelier; S Raymond
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication.
Allal Houssaini; Anne-Geneviève Marcelin; Veronica Miller; Lambert Assoumou; Vincent Calvez; Philippe Flandre
Scoring methods for building genotypic scores: an application to Didanosine resistance in a large derivation set.
Marc Wirden; Manuela Bonmarchand; Vincent Calvez; Slim Fourati; Christine Katlama; Nadine Ktorza; Luminita Schneider; Anne Simon; Cathia Soulié; Roland Tubiana; Marc-Antoine Valantin; Anne-Geneviève Marcelin
Pitfalls of HIV genotypic tropism testing after treatment interruption.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vincent Calvez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Patricia Recordon-Pinson; C Soulie; Pantxika Bellecave; Vincent Calvez; Diane Descamps; H Fleury; P R Harrigan; J Izopet; Anne-Geneviève Marcelin; Bernard Masquelier; S Raymond
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication.
Antimicrobial agents and chemotherapy 2013;57(2):930-5.
2013: Allal Houssaini; Anne-Geneviève Marcelin; Veronica Miller; Lambert Assoumou; Vincent Calvez; Philippe Flandre
Scoring methods for building genotypic scores: an application to Didanosine resistance in a large derivation set.
PloS one 2013;8(3):e59014.
2013: Marc Wirden; Manuela Bonmarchand; Vincent Calvez; Slim Fourati; Christine Katlama; Nadine Ktorza; Luminita Schneider; Anne Simon; Cathia Soulié; Roland Tubiana; Marc-Antoine Valantin; Anne-Geneviève Marcelin
Pitfalls of HIV genotypic tropism testing after treatment interruption.
The Journal of antimicrobial chemotherapy 2013;68(1):188-9.
2013: Almoustapha Issiaka MAIGA; Anne-Geneviève Marcelin; Robert Murphy; Aboubacar Alassane Oumar; Yaya Dit Sadio Sarro; Aliou Sylla; Babafemi Taiwo; Anatole Tounkara; Mamadou Cisse; Fatoumata Daou; Fodie Diallo; Djeneba Bocar Fofana; Christine Katlama; Aichatou Chehy Maiga; Zaina Ait-Arkoub; Vincent Calvez
Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.
AIDS research and human retroviruses 2013;29(1):182-6.
2012: Almoustapha Issiaka Maiga; Issouf Alassane Maiga; Moussa Y Maiga; Vincent Calvez; Mamadou Cisse; Fodié Diallo; Dionke Fofana; Djeneba Bocar Fofana; Christine Katlama; Robert Murphy; Aliou Sylla; Babafemi Taiwo; Anatole Tounkara; Hamar A Traore; Anne-Geneviève Marcelin
Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting.
The Journal of antimicrobial chemotherapy 2012;67(12):2943-8.
2012: Almoustapha Issiaka MAIGA; Moussa Y Maiga; Anne-Geneviève Marcelin; Robert Murphy; Sudhir Penugonda; Aliou Sylla; Nobel Bellosillo; Baiba Berzins; Vincent Calvez; Fodie Diallo; Djeneba Bocar Fofana; Drissa Katile; Anatole Tounkara; Hamar A Traore; Babafemi Taiwo
Connection domain mutations during antiretroviral treatment failure in Mali: frequencies and impact on reverse transcriptase inhibitor activity.
Journal of acquired immune deficiency syndromes (1999) 2012;61(3):293-6.
2012: Isabelle Malet; Vincent Calvez; Anne-Geneviève Marcelin
The future of integrase inhibitors of HIV-1.
Current opinion in virology 2012;2(5):580-7.
2012: Isabelle Malet; Vincent Calvez; Philippe Flandre; Slim Fourati; Pierre-Marie Girard; Stéphanie Haim-Boukobza; Christine Katlama; Laurence Morand-Joubert; Theresa Pattery; Sophie Sayon; Anne Simon; Marc Wirden; Anne-Geneviève Marcelin
Risk factors for raltegravir resistance development in clinical practice.
The Journal of antimicrobial chemotherapy 2012;67(10):2494-500.
2012: Slim Fourati; Christine Katlama; Sidonie Lambert-Niclot; Isabelle Malet; Zaina Ait-Arkoub; Vincent Calvez; Guislaine Carcelain; Benjamin Descours; Benoit Mory; Cathia Soulie; Marc-Antoine Valantin; Anne-Geneviève Marcelin
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs.
The Journal of antimicrobial chemotherapy 2012;67(10):2323-6.
2012: Slim Fourati; Christine Katlama; Sidonie Lambert; Isabelle Malet; Sophie Sayon; Anne Simon; Cathia Soulie; Marc Wirden; Vincent Calvez; Philippe Flandre; Djeneba B Fofana; Anne-Geneviève Marcelin
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure.
AIDS (London, England) 2012;26(13):1619-24.
2012: Anne-Geneviève Marcelin; Anne Simon; Marc-Antoine Valantin; Marc Wirden; Patrick Yeni; Charlotte Charpentier; Diane Descamps; Christine Katlama; Roland Landman; Camille Aubron-Olivier; Vincent Calvez
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
The Journal of antimicrobial chemotherapy 2012;67(6):1475-8.
2012: Sidonie Lambert-Niclot; Gilles Lefebvre; Céline Beaudoux; Manuela Bonmarchand; Fabienne Caby; Vincent Calvez; Marc Dommergues; Philippe Flandre; Michèle Naouri; Catherine Poirot; Benoit Schubert; Roland Tubiana; Anne-Geneviève Marcelin
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey.
AIDS (London, England) 2012;26(8):971-5.
2012: Xiaoju Ni; Osamuede Osemwota; Safwat Abdel Azeim; Rohit Arora; Vincent Calvez; Elodie Laine; Anne-Geneviève Marcelin; Jean-François Mouscadet; Luba Tchertanov
In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors.
Advances in virology 2012;2012():548657.
2012: Allal Houssaïni; Anne-Geneviève Marcelin; Jean Michel Molina; Lambert Assoumou; Vincent Calvez; Philippe Flandre
Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data.
AIDS research and treatment 2012;2012():478467.
2011: Isabelle Malet; Laurence Morand-Joubert; Carlo Federico Perno; Sophie Sayon; Margriet Van Houtte; Marc Wirden; Daniele Armenia; Françoise Brun-Vézinet; Vincent Calvez; André Capt; Francesca Ceccherini-Silberstein; Charlotte Charpentier; Diane Descamps; Slim Fourati; Anne-Geneviève Marcelin
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.
The Journal of antimicrobial chemotherapy 2011;66(12):2827-30.
2011: Sidonie Lambert-Niclot; Gilles Peytavin; Marc-Antoine Valantin; Yazdan Yazdanpanah; Michele Algarte-Genin; Vincent Calvez; Claudine Duvivier; Philippe Flandre; Pierre-Marie Girard; Stephanie Haim-Boukobza; Christine Katlama; Anne-Genevieve Marcelin
Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy.
The Journal of infectious diseases 2011;204(8):1211-6.
2011: Sidonie Lambert-Niclot; Manuela Bonmarchand; Vincent Calvez; Stephanie Dominguez; Philippe Flandre; Allal Houssaini; Gilles Peytavin; Catherine Poirot; Marie Prades; Benoit Schubert; Cathia Soulié; Roland Tubiana; Anne-Geneviève Marcelin
Effect of antiretroviral drugs on the quality of semen.
Journal of medical virology 2011;83(8):1391-4.
2011: Marc Wirden; Zaina Ait-Arkoub; Ana Canestri; S Fourati; Christine Katlama; Anne-Geneviève Marcelin; Anne Simon; C Soulie; M Thevenin; Roland Tubiana; Vincent Calvez
Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations.
Journal of clinical microbiology 2011;49(7):2700-2.
2011: Isabelle Malet; Anne-Geneviève Marcelin; Bernard Masquelier; Carlo Federico Perno; Sophie Sayon; Marc Wirden; Daniele Armenia; Vincent Calvez; Lavinia Fabeni; Slim Fourati; Christine Katlama; Francesca Ceccherini-Silberstein
Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients.
The Journal of antimicrobial chemotherapy 2011;66(7):1481-3.
2011: Marc Wirden; Cathia Soulie; Marc-Antoine Valantin; Slim Fourati; Anne Simon; Sidonie Lambert-Niclot; Manuela Bonmarchand; Cyril Clavel-Osorio; Anne-Geneviève Marcelin; Christine Katlama; Vincent Calvez
Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia.
The Journal of antimicrobial chemotherapy 2011;66(4):709-12.
2011: Lucile Larrouy; Sidonie Lambert-Niclot; Charlotte Charpentier; Slim Fourati; Benoit Visseaux; Cathia Soulié; Marc Wirden; Christine Katlama; Patrick Yeni; Françoise Brun-Vézinet; Vincent Calvez; Anne-Geneviève Marcelin; Diane Descamps
Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir.
Antimicrobial agents and chemotherapy 2011;55(4):1754-7.
2011: Stéphanie Haïm-Boukobza; Laurence Morand-Joubert; Philippe Flandre; Nadia Valin; Slim Fourati; Sophie Sayon; Marc Lavignon; Anne Simon; Pierre-Marie Girard; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml.
AIDS (London, England) 2011;25(3):341-4.
2011: Charlotte Charpentier; Pantxika Bellecave; Mohamed Cisse; Saidou Mamadou; Mandiou Diakite; Gilles Peytavin; Stéphanie Tchiombiano; Pierre Teisseire; Louis Pizarro; Alexandre Storto; Françoise Brun-Vézinet; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin; Bernard Masquelier; Diane Descamps
High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger.
Antiviral therapy 2011;16(3):429-33.
2010: Diane Descamps; Marie-Laure Chaix; Brigitte Montes; Sophie Pakianather; Charlotte Charpentier; Alexandre Storto; Francis Barin; Georges DOS SANTOS; Anne Krivine; Constance Delaugerre; Jacques Izopet; Anne-Geneviève Marcelin; Anne Maillard; Laurence Morand-Joubert; Coralie Pallier; Jean-Christophe Plantier; Catherine Tamalet; Jacqueline Cottalorda; Delphine Desbois; Vincent Calvez; Françoise Brun Vezinet; Bernard Masquelier; Dominique Costagliola
Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.
The Journal of antimicrobial chemotherapy 2010;65(12):2620-7.
2010: Sidonie Lambert-Niclot; Gilles Peytavin; Claudine Duvivier; Catherine Poirot; Michèle Algarte-Genin; Sophie Pakianather; Jean-Luc Meynard; Marc-Antoine Valantin; Jean-Michel Molina; Philippe Flandre; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapy.
Antimicrobial agents and chemotherapy 2010;54(11):4910-3.
2010: Cathia Soulié; Slim Fourati; Sidonie Lambert-Niclot; Roland Tubiana; Ana Canestri; Pierre-Marie Girard; Christine Katlama; Laurence Morand-Joubert; Vincent Calvez; Anne-Geneviève Marcelin
HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis.
AIDS (London, England) 2010;24(15):2412-4.
2010: Slim Fourati; Isabelle Malet; Mawuena Binka; Stephanie Boukobza; Marc Wirden; Sophie Sayon; Anne Simon; Christine Katlama; Viviana Simon; Vincent Calvez; Anne-Geneviève Marcelin
Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals.
AIDS (London, England) 2010;24(15):2313-21.
2010: Giovanna Melica; Ana Canestri; Gilles Peytavin; Jean D Lelievre; Magali Bouvier-Alias; Cyril Clavel; Vincent Calvez; Anne S Lascaux; Christine Katlama; Yves Levy
Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms.
AIDS (London, England) 2010;24(13):2130-3.
2010: Fabienne Caby; Nadia Valin; Anne Genevieve Marcelin; Luminata Schneider; Régis Andrade; Marguerite Guiguet; Roland Tubiana; Ana Canestri; Marc-Antoine Valantin; Gilles Peytavin; Jérome Pacanowski; Laurence Morand-Joubert; Vincent Calvez; Pierre Marie Girard; Christine Katlama
Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients.
Scandinavian journal of infectious diseases 2010;42(6-7):527-32.
2010: Cathia Soulié; Slim Fourati; Sidonie Lambert-Niclot; Isabelle Malet; Marc Wirden; Roland Tubiana; Marc-Antoine Valantin; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists.
The Journal of antimicrobial chemotherapy 2010;65(4):749-51.
2010: Philip M Grant; Jonathan Taylor; Andrew B Nevins; Vincent Calvez; Anne-Geneviève Marcelin; Marc Wirden; Andrew R Zolopa
International cohort analysis of the antiviral activities of zidovudine and tenofovir in the presence of the K65R mutation in reverse transcriptase.
Antimicrobial agents and chemotherapy 2010;54(4):1520-5.
2010: Amélie Guihot; Roland Tubiana; Guillaume Breton; Anne-Geneviève Marcelin; Assia Samri; Lambert Assoumou; Emilia Goncalves; François Bricaire; Dominique Costagliola; Vincent Calvez; Christine Rouzioux; Brigitte Autran; Christine Katlama; Guislaine Carcelain
Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
AIDS (London, England) 2010;24(4):614-7.
2010: Almoustapha Issiaka Maïga; Diane Descamps; Laurence Morand-Joubert; Isabelle Malet; Anne Derache; Mamadou Cisse; Victoria Koita; Alain Akonde; Bah Diarra; Marc Wirden; Anatole Tounkara; Yvan Verlinden; Christine Katlama; Dominique Costagliola; Bernard Masquelier; Vincent Calvez; Anne-Geneviève Marcelin
Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes.
Antimicrobial agents and chemotherapy 2010;54(2):728-33.
2010: Anne-Geneviève Marcelin; Philippe Flandre; Diane Descamps; Laurence Morand-Joubert; Charlotte Charpentier; Jacques Izopet; Mary-Anne Trabaud; Henia Saoudin; Constance Delaugerre; Catherine Tamalet; Jacqueline Cottalorda; Magali Bouvier-Alias; Dominique Bettinger; Georges DOS SANTOS; Annick Ruffault; Chakib Alloui; Cecile Henquell; Sylvie Rogez; Francis Barin; Anne Signori-Schmuck; Sophie Vallet; Bernard Masquelier; Vincent Calvez
Factors associated with virological response to etravirine in nonnucleoside reverse transcriptase inhibitor-experienced HIV-1-infected patients.
Antimicrobial agents and chemotherapy 2010;54(1):72-7.
2010: Olivier Delelis; Sylvain Thierry; Frédéric Subra; Françoise Simon; Isabelle Malet; Chakib Alloui; Sophie Sayon; Vincent Calvez; Eric Deprez; Anne-Geneviève Marcelin; Luba Tchertanov; Jean-François Mouscadet
Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo.
Antimicrobial agents and chemotherapy 2010;54(1):491-501.
2009: Marc Wirden; Anne Simon; Luminita Schneider; Roland Tubiana; Isabelle Malet; Hocine Ait Mohand; Gilles Peytavin; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug.
The Journal of antimicrobial chemotherapy 2009;64(5):1087-90.
2009: Jean-François Mouscadet; Rohit Arora; Joseph André; Jean-Christophe Lambry; Olivier Delelis; Isabelle Malet; Anne-Geneviève Marcelin; Vincent Calvez; Luba Tchertanov
HIV-1 IN alternative molecular recognition of DNA induced by raltegravir resistance mutations.
Journal of molecular recognition : JMR 2009;22(6):480-94.
2009: Soo-Yon Rhee; W Jeffrey Fessel; Tommy F Liu; Natalia M Marlowe; Charles M Rowland; Richard Rode; Anne-Mieke Vandamme; Kristel Van Laethem; Françoise Brun Vezinet; Vincent Calvez; Jonathan Taylor; Leo Hurley; Michael Horberg; Robert W Shafer
Predictive value of HIV-1 genotypic resistance test interpretation algorithms.
The Journal of infectious diseases 2009;200(3):453-63.
2009: Cathia Soulié; Lambert Assoumou; Jade Ghosn; Claudine Duvivier; Gilles Peytavin; Zaina Ait-Arkoub; Jean-Michel Molina; Dominique Costagliola; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibitor + nucleoside reverse transcriptase inhibitor in the randomized ANRS 121 trial.
AIDS (London, England) 2009;23(12):1605-8.
2009: Robert L Murphy; Brigitte Autran; Christine Katlama; Gilles Brucker; Patrice Debre; Vincent Calvez; Bonaventura Clotet; Nathan Clumeck; Dominique Costagliola; Steven G Deeks; Lucy Dorrell; Jose Gatell; Ashley Haase; Michel Klein; Adriano Lazzarin; Andrew J McMichael; Laura Papagno; Timothy W Schacker; Simon Wain-Hobson; Bruce D Walker; Michael Youle
A step ahead on the HIV collaboratory.
Science (New York, N.Y.) 2009;324(5932):1264-5.
2009: Cathia Soulié; Roland Tubiana; Anne Simon; Sidonie Lambert-Niclot; Isabelle Malet; Ana Canestri; Christel Brunet; Robert Murphy; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):60-4.
2009: Marc Wirden; Roland Tubiana; F Marguet; I Leroy; Anne Simon; Manuela Bonmarchand; Zaina Ait-Arkoub; R Murphy; Anne-Geneviève Marcelin; Christine Katlama; Vincent Calvez
Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.
Journal of clinical microbiology 2009;47(5):1543-5.
2009: Isabelle Malet; Olivier Delelis; Cathia Soulie; Marc Wirden; Luba Tchertanov; Philippe Mottaz; Gilles Peytavin; Christine Katlama; Jean-François Mouscadet; Vincent Calvez; Anne-Geneviève Marcelin
Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.
The Journal of antimicrobial chemotherapy 2009;63(4):795-804.
2009: Diane Descamps; Sidonie Lambert-Niclot; Anne-Geneviève Marcelin; Gilles Peytavin; Bénédicte Roquebert; Christine Katlama; Patrick Yeni; Mathieu Felices; Vincent Calvez; Françoise Brun-Vézinet
Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients.
The Journal of antimicrobial chemotherapy 2009;63(3):585-92.
2009: Olivier Delelis; Isabelle Malet; Li Na; Luba Tchertanov; Vincent Calvez; Anne-Genevieve Marcelin; Frederic Subra; Eric Deprez; Jean-François Mouscadet
The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation.
Nucleic acids research 2009;37(4):1193-201.
2009: David Rey; Bruno Hoen; P Chavanet; Marie-Paule Schmitt; G Hoizey; P Meyer; Gilles Peytavin; B Spire; Clotilde Allavena; M Diemer; T May; J L Schmit; M Duong; Vincent Calvez; Jean-Marie Lang
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
The Journal of antimicrobial chemotherapy 2009;63(2):380-8.
2009: Marc Wirden; Sidonie Lambert-Niclot; Anne-Geneviève Marcelin; Luminita Schneider; Hocine Ait Mohand; Christel Brunet; Francis Angleraud; Sylvain Amard; Christine Katlama; Vincent Calvez
Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients.
AIDS (London, England) 2009;23(1):95-9.
2009: Gilles Peytavin; Vincent Calvez; Christine Katlama
[CCR5 antagonists: a new class of antiretrovirals].
Thérapie 2009;64(1):9-16.
2009: Almoustapha-Issiaka Maïga; Isabelle Malet; Cathia Soulie; Anne Derache; Victoria Koita; Bahia Amellal; Luba Tchertanov; Olivier Delelis; Laurence Morand-Joubert; Jean-François Mouscadet; Robert Murphy; Mamadou Cissé; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.
Antiviral therapy 2009;14(1):123-9.
2008: Anne-Geneviève Marcelin; Philippe Flandre; Jean-Michel Molina; Christine Katlama; Patrick Yeni; François Raffi; Zeina Antoun; Mounir Ait-Khaled; Vincent Calvez
Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
Antimicrobial agents and chemotherapy 2008;52(12):4251-7.
2008: Vincent Soriano; Anna María Geretti; Carlo Federico Perno; Gerd Fätkenheuer; Deenan Pillay; Jacques Reynes; Giuseppe Tambussi; Vincent Calvez; José Alcamí; Juergen Rockstroh
Optimal use of maraviroc in clinical practice.
AIDS (London, England) 2008;22(17):2231-40.
2008: Sidonie Lambert-Niclot; Philippe Flandre; Isabelle Malet; Ana Canestri; Cathia Soulié; Roland Tubiana; Christel Brunet; Marc Wirden; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease.
The Journal of antimicrobial chemotherapy 2008;62(5):905-8.
2008: Cathia Soulié; Isabelle Malet; Sidonie Lambert-Niclot; Roland Tubiana; Monique Thévenin; Anne Simon; Robert Murphy; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients.
AIDS (London, England) 2008;22(16):2212-4.
2008: Bahia Amellal; R Murphy; A Maiga; G Brucker; Christine Katlama; Vincent Calvez; A G Marcelin
Stability of HIV RNA in plasma specimens stored at different temperatures.
HIV medicine 2008;9(9):790-3.
2008: H Ait-Mohand; M Bonmarchand; M Guiguet; L Slama; F Marguet; A Behin; B Amellal; Y Bennai; Gilles Peytavin; Vincent Calvez; Gilles Pialoux; R Murphy; Christine Katlama
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.
HIV medicine 2008;9(9):738-46.
2008: Claudine Duvivier; Jade Ghosn; Lambert Assoumou; Cathia Soulié; Gilles Peytavin; Vincent Calvez; Michèle Algarté Génin; Jean-Michel Molina; Olivier Bouchaud; Christine Katlama; Dominique Costagliola
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
The Journal of antimicrobial chemotherapy 2008;62(4):797-808.
2008: Marc-Antoine Valantin; Emilie Lanoy; Michelle Bentata; O Kalmykova; A Boutekadjirt; Clotilde Allavena; Willy Rozenbaum; Gilles Peytavin; Bahia Amellal; Vincent Calvez; Dominique Costagliola; Christine Katlama
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.
HIV medicine 2008;9(8):625-35.
2008: Anne-Geneviève Marcelin; Bernard Masquelier; Diane Descamps; Jacques Izopet; Charlotte Charpentier; Chakib Alloui; Magali Bouvier-Alias; Anne Signori-Schmuck; Brigitte Montes; Marie-Laure Chaix; Corinne Amiel; Georges Dos Santos; Annick Ruffault; Francis Barin; Gilles Peytavin; Marc Lavignon; Philippe Flandre; Vincent Calvez
Tipranavir-ritonavir genotypic resistance score in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2008;52(9):3237-43.
2008: Anne Derache; Almoustapha Issiaka MAIGA; Ousmane Traore; Alain Akonde; Mamadou Cisse; Bernard Jarrousse; Victoria Koita; Bah Diarra; Guislaine Carcelain; Francis Barin; Cecilia Pizzocolo; Louis Pizarro; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
The Journal of antimicrobial chemotherapy 2008;62(3):456-63.
2008: Diane Descamps; Lambert Assoumou; Bernard Masquelier; Anne-Geneviève Marcelin; Souhila Saidi; Catherine Tamalet; Jacqueline Cottalorda; Jean-Christophe Plantier; Brigitte Montes; Jacques Izopet; Gilles Peytavin; Sabine Yerly; Véronique Schneider; Constance Delaugerre; Virginie Ferré; Annick Ruffault; Coralie Pallier; Laurence Morand-Joubert; Marie-Laure Chaix; Vincent Calvez; Françoise Brun-Vézinet; Dominique Costagliola
HIV-1-infected patients from the French National Observatory experiencing virological failure while receiving enfuvirtide.
The Journal of antimicrobial chemotherapy 2008;62(3):451-5.
2008: Brigitte Autran; Robert L Murphy; Dominique Costagliola; Roland Tubiana; Bonaventura Clotet; Jose Gatell; Schlomo Staszewski; Norma Wincker; Lambert Assoumou; Raphaelle El Habib; Vincent Calvez; Bruce Walker; Christine Katlama
Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).
AIDS (London, England) 2008;22(11):1313-22.
2008: C Delaugerre; P Flandre; A G Marcelin; D Descamps; C Tamalet; J Cottalorda; V Schneider; S Yerly; Jerome LeGoff; L Morand-Joubert; M L Chaix; Dominique Costagliola; Vincent Calvez
National survey of the prevalence and conditions of selection of HIV-1 reverse transcriptase K70E mutation.
Journal of medical virology 2008;80(5):762-5.
2008: Isabelle Malet; Cathia Soulie; Luba Tchertanov; Anne Derache; Bahia Amellal; Ousmane Traore; Anne Simon; Christine Katlama; Jean-François Mouscadet; Vincent Calvez; Anne-Geneviève Marcelin
Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.
Journal of medical virology 2008;80(5):754-61.
2008: Jade Ghosn; Ines De Montgolfier; Chantal Cornélie; Stephanie Dominguez; Claire Pérot; Gilles Peytavin; Anne-Geneviève Marcelin; Michèle Pauchard; Zineb Ouagari; Manuela Bonmarchand; Rachid Agher; Vincent Calvez; François Bricaire; Marc Dommergues; Christine Katlama; Roland Tubiana
Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.
Antimicrobial agents and chemotherapy 2008;52(4):1542-4.
2008: Isabelle Malet; Olivier Delelis; Marc-Antoine Valantin; Brigitte Montes; Cathia Soulie; Marc Wirden; Luba Tchertanov; Gilles Peytavin; Jacques Reynes; Jean-François Mouscadet; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.
Antimicrobial agents and chemotherapy 2008;52(4):1351-8.
2008: Cathia Soulié; Vincent Calvez
[HIV tropism assays when first CCR5-antagonist becomes available].
Médecine et maladies infectieuses 2008;38 Suppl 1():S7-11.
2008: Sidonie Lambert-Niclot; Philippe Flandre; Ana Canestri; Gilles Peytavin; Christine Blanc; Rachid Agher; Cathia Soulié; Marc Wirden; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir.
Antimicrobial agents and chemotherapy 2008;52(2):491-6.
2008: Cathia Soulié; Anne Derache; C Aimé; Anne-Geneviève Marcelin; Guislaine Carcelain; Anne Simon; Christine Katlama; Vincent Calvez
Comparison of two genotypic algorithms to determine HIV-1 tropism.
HIV medicine 2008;9(1):1-5.
2007: Anne-Geneviève Marcelin; Bernard Jarrousse; Anne Derache; Madina Ba; Marie-Léa Dakouo; Alioune Doumbia; Ibrahima Haidara; Almoustapha Maïga; Guislaine Carcelain; Gilles Peytavin; Christine Katlama; Vincent Calvez
HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.
AIDS (London, England) 2007;21(17):2341-3.
2007: Cathia Soulié; Anne-Geneviève Marcelin; Jade Ghosn; Bahia Amellal; Lambert Assoumou; Sidonie Lambert; Claudine Duvivier; Dominique Costagliola; Christine Katlama; Vincent Calvez
HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART.
AIDS (London, England) 2007;21(16):2243-5.
2007: Anne-Geneviève Marcelin; Jérome Motol; Amélie Guihot; Eric Caumes; Jean-Paul Viard; Elisabeth Dussaix; Jacques Cadranel; Camille Frances; Guislaine Carcelain; Vincent Calvez; Nicolas Dupin
Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.
The Journal of infectious diseases 2007;196(8):1163-6.
2007: Marc Buffet; Philippe A Grange; Philippe Gerhardt; Agnès Carlotti; Vincent Calvez; Anne Bianchi; Nicolas Dupin
Diagnosing Treponema pallidum in secondary syphilis by PCR and immunohistochemistry.
The Journal of investigative dermatology 2007;127(10):2345-50.
2007: B Amellal; C Katlama; Vincent Calvez
Evaluation of the use of dried spots and of different storage conditions of plasma for HIV-1 RNA quantification.
HIV medicine 2007;8(6):396-400.
2007: Martin S King; Richard Rode; Isabelle Cohen-Codar; Vincent Calvez; Anne-Geneviève Marcelin; George J Hanna; Dale J Kempf
Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2007;51(9):3067-74.
2007: Ana Canestri; Mamadou Cisse; Anne-Geneviève Marcelin; Gilles Peytavin; Emmanuel Traore; Lambert Assoumou; Ousmane Traore; Victoria Koita; Fodie Diallo; Awa Thiero Sangare; Mayrama Koita Sidibé; Vincent Calvez; Aliou Sylla; Christine Katlama; Roland Tubiana
Experience of indinavir/ritonavir 400/100 mg twice-daily highly active antiretroviral therapy-containing regimen in HIV-1-infected patients in Bamako, Mali: the NOGOMA Study.
Journal of acquired immune deficiency syndromes (1999) 2007;45(4):477-9.
2007: Constance Delaugerre; Anne-Geneviève Marcelin; Cathia Soulié; Marie-Laure Chaix; Christine Katlama; Pierre-Marie Girard; Vincent Calvez; Laurence Morand-Joubert
Transmission of multidrug-resistant HIV-1: 5 years of immunological and virological survey.
AIDS (London, England) 2007;21(10):1365-7.
2007: Bahia Amellal; Clotilde Allavena; E André-Garnier; Virginie Ferré; Marc-Antoine Valantin; Jean-François Delfraissy; Alain Lafeuillade; Manuela Bonmarchand; Vincent Calvez; François Raffi
Constant mitochondrial DNA levels in blood leukocytes of patients enrolled in a NRTI-free therapeutic trial (BIKS-2 study).
The Journal of infection 2007;54(6):603-8.
2007: Isabelle Malet; Marc Wirden; Anne Derache; Anne Simon; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients.
AIDS (London, England) 2007;21(7):871-3.
2007: Isabelle Malet; Bénédicte Roquebert; Cécile Dalban; Marc Wirden; Bahia Amellal; Rachid Agher; Anne Simon; Christine Katlama; Dominique Costagliola; Vincent Calvez; Anne-Geneviève Marcelin
Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients.
The Journal of infection 2007;54(4):367-74.
2007: Bénédicte Roquebert; Marc Wirden; Anne Simon; Jérome Deval; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in naïve and pre-treated HIV infected patients.
Journal of medical virology 2007;79(3):207-11.
2007: Philippe Flandre; Colombe Chappey; Anne-Geneviève Marcelin; Kirk Ryan; Jen-Fue Maa; Michael Bates; Daniel Seekins; Marie Charlotte Bernard; Vincent Calvez; Jean Michel Molina
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
The Journal of infectious diseases 2007;195(3):392-8.
2007: Stephanie Dominguez; Jade Ghosn; Gilles Peytavin; Hassane Izzedine; Marc Wirden; Nadine Ktorza; M Miller; Camille Aubron-Olivier; Aldo Trylesinski; Vincent Calvez; Gilbert Deray; Christine Katlama
Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.
Journal of medical virology 2007;79(2):105-10.
2007: Anne Derache; Ousmane Traore; Victoria Koita; Aliou Sylla; Roland Tubiana; Anne Simon; Ana Canestri; Guislaine Carcelain; Christine Katlama; Vincent Calvez; Mamadou Cisse; Anne-Geneviève Marcelin
Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
Antiviral therapy 2007;12(1):123-9.
2007: Anne-Geneviève Marcelin; Philippe Flandre; Carmen de Mendoza; Bénédicte Roquebert; Gilles Peytavin; Luisa Valer; Marc Wirden; Sarah Abbas; Christine Katlama; Vincent Soriano; Vincent Calvez
Clinical validation of saquinavir/ritonavir genotypic resistance score in protease-inhibitor-experienced patients.
Antiviral therapy 2007;12(2):247-52.
2007: Geneviève Chêne; Bahia Amellal; Gaëlle Pédrono; Karine Gourlain; Corinne Rancinan; Valérie Journot; Laurent Cotte; Pierre Palmer; Nathalie De Castro; Vincent Calvez; Jean-Michel Molina
Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
AIDS research and human retroviruses 2007;23(1):54-61.
2007: Anne-Geneviève Marcelin; Vincent Calvez; E Dussaix
KSHV after an organ transplant: should we screen?
Current topics in microbiology and immunology 2007;312():245-62.
2006: Marc Wirden; Bénédicte Roquebert; Anne Derache; Anne Simon; Claudine Duvivier; Jade Ghosn; Stephanie Dominguez; Véronique Boutonnet; Zaina Ait-Arkoub; Christine Katlama; Vincent Calvez; Anne-Geneviève Marcelin
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 2006;50(7):2553-6.
2006: Anne-Geneviève Marcelin; Vincent Calvez
[HIV drug resistance].
La Revue du praticien 2006;56(9):978-86.
2006: Anne-Geneviève Marcelin; Corine Chazallon; Laurence Gérard; Yacine Saïdi; Jean-Pierre Aboulker; Pierre-Marie Girard; Vincent Calvez; Christophe Piketty
External validation of atazanavir/ritonavir genotypic score in HIV-1 protease inhibitor-experienced patients.
Journal of acquired immune deficiency syndromes (1999) 2006;42(1):127-8.
2006: Diane Descamps; Constance Delaugerre; Bernard Masquelier; Annick Ruffault; Anne-Geneviève Marcelin; Jacques Izopet; Marie-Laure Chaix; Vincent Calvez; Françoise Brun-Vézinet; Dominique Costagliola
Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.
Journal of medical virology 2006;78(2):153-60.
2006: Bénédicte Roquebert; Isabelle Malet; Marc Wirden; Roland Tubiana; Marc-Antoine Valantin; Anne Simon; Christine Katlama; Gilles Peytavin; Vincent Calvez; Anne-Geneviève Marcelin
Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors.
AIDS (London, England) 2006;20(2):287-9.
2006: Samir Vora; Anne-Geneviève Marcelin; Huldrych Günthard; Philippe Flandre; Hans Hirsch; Bernard Masquelier; Annelies Zinkernagel; Gilles Peytavin; Vincent Calvez; Luc Perrin; Sabine Yerly
Clinical validation of atazanavir/ritonavir genotypic resistance score in protease inhibitor-experienced patients.
AIDS (London, England) 2006;20(1):35-40.
2006: Anne-Geneviève Marcelin; Philippe Flandre; Andre Furco; Marc Wirden; Jean-Michel Molina; Vincent Calvez
Impact of HIV-1 reverse transcriptase polymorphism at codons 211 and 228 on virological response to didanosine.
Antiviral therapy 2006;11(6):693-9.
2006: Ana Canestri; Jade Ghosn; Marc Wirden; Françoise Marguet; Nadine Ktorza; Imane Boubezari; Stephanie Dominguez; Philippe Bossi; Eric Caumes; Vincent Calvez; Christine Katlama
Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance.
Antiviral therapy 2006;11(5):561-6.
2006: Christophe Piketty; Laurence Gérard; Corine Chazallon; Anne-Geneviève Marcelin; François Clavel; Anne-Marie Taburet; Vincent Calvez; Isabelle Madelaine-Chambrin; Jean-Michel Molina; Jean-Pierre Aboulker; Pierre-Marie Girard
Salvage therapy with atazanavir/ritonavir combined to tenofovir in HIV-infected patients with multiple treatment failures: randomized ANRS 107 trial.
Antiviral therapy 2006;11(2):213-21.
2006: Yves Benhamou; Vincent Thibault; Pamela Vig; Vincent Calvez; Anne-Geneviève Marcelin; Marie-Hélène Fievet; Graeme Currie; Chuy G Chang; Lu Biao; Shelly Xiong; Carol L Brosgart; Thierry Poynard
Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.
Journal of hepatology 2006;44(1):62-7.
2005: Constance Delaugerre; Gilles Peytavin; Stephanie Dominguez; Anne-Geneviève Marcelin; Claudine Duvivier; Karine Gourlain; Bahia Amellal; Mayeule Legrand; François Raffi; Dominique Costagliola; Christine Katlama; Vincent Calvez
Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).
Journal of medical virology 2005;77(3):345-50.
2005: Jade Ghosn; Marc Wirden; Nadine Ktorza; Gilles Peytavin; Hocine Aït-Mohand; Luminita Schneider; Stephanie Dominguez; François Bricaire; Vincent Calvez; Dominique Costagliola; Christine Katlama
No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.
AIDS (London, England) 2005;19(15):1643-7.
2005: Anne-Geneviève Marcelin; Philippe Flandre; Gilles Peytavin; Vincent Calvez
Predictors of virologic response to ritonavir-boosted protease inhibitors.
AIDS reviews 2005;7(4):225-32.
2005: Bernard Masquelier; Dominique Costagliola; Anne Schmuck; Jacqueline Cottalorda; Véronique Schneider; Jacques Izopet; Vincent Calvez; Diane Descamps; Cécile Poggi; Françoise Brun-Vézinet
Prevalence of complete resistance to at least two classes of antiretroviral drugs in treated HIV-1-infected patients: a French nationwide study.
Journal of medical virology 2005;76(4):441-6.
2005: Roland Tubiana; Guislaine Carcelain; Muriel Vray; Karine Gourlain; Cécile Dalban; Aziza Chermak; Claire Rabian; Daniel Vittecoq; Anne Simon; Elisabeth Bouvet; Raphaelle El Habib; Dominique Costagliola; Vincent Calvez; Brigitte Autran; Christine Katlama
Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).
Vaccine 2005;23(34):4292-301.
2005: David Montani; Anne-Geneviève Marcelin; Olivier Sitbon; Vincent Calvez; Gérald Simonneau; Marc Humbert
Human herpes virus 8 in HIV and non-HIV infected patients with pulmonary arterial hypertension in France.
AIDS (London, England) 2005;19(11):1239-40.
2005: Valérie Martinez; Anne-Geneviève Marcelin; Jean-Pierre Morini; Jean Deleuze; Anne Krivine; Isabelle Gorin; Sabine Yerly; Luc Perrin; Gilles Peytavin; Vincent Calvez; Nicolas Dupin
HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen.
AIDS (London, England) 2005;19(10):1065-9.
2005: Marc Wirden; Anne-Geneviève Marcelin; Anne Simon; Myriam Kirstetter; Roland Tubiana; Marc-Antoine Valantin; Luc Paris; Manuela Bonmarchand; Francoise Conan; Laurence Kalkias; Christine Katlama; Vincent Calvez
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients.
Journal of medical virology 2005;76(3):297-301.
2005: Philippe A Grange; Anne-Geneviève Marcelin; Vincent Calvez; Caroline Chauvel; Jean-Paul Escande; Nicolas Dupin
Salivary lactoferrin is recognized by the human herpesvirus-8.
The Journal of investigative dermatology 2005;124(6):1249-58.
2005: Anne-Geneviève Marcelin; Philippe Flandre; Juliette Pavie; Nathalie Schmidely; Marc Wirden; Olivier Lada; Dan Chiche; Jean-Michel Molina; Vincent Calvez
Clinically relevant genotype interpretation of resistance to didanosine.
Antimicrobial agents and chemotherapy 2005;49(5):1739-44.
2005: Anne-Geneviève Marcelin; Isabelle Cohen-Codar; Martin S King; Philippe Colson; Emmanuel Guillevic; Diane Descamps; Claire Lamotte; Véronique Schneider; Jacques Ritter; MICHEL SEGONDY; Hélène Peigue-Lafeuille; Laurence Morand-Joubert; Anne Schmuck; Annick Ruffault; Pierre Palmer; Marie-Laure Chaix; Vincent Mackiewicz; Véronique Brodard; Jacques Izopet; Jacqueline Cottalorda; Evelyne Kohli; Jean-Pierre Chauvin; Dale J Kempf; Gilles Peytavin; Vincent Calvez
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2005;49(5):1720-6.
2005: Marc Buffet; Michaël Schwarzinger; Bahia Amellal; Karine Gourlain; Patrick Bui; Marianne Prévot; Jean Deleuze; Jean-Pierre Morini; Isabelle Gorin; Vincent Calvez; Nicolas Dupin
Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;33(1):60-4.
2005: Marc Wirden; Isabelle Malet; Anne Derache; Anne-Geneviève Marcelin; Bénédicte Roquebert; Anne Simon; Myriam Kirstetter; Laurence Morand Joubert; Christine Katlama; Vincent Calvez
Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution.
AIDS (London, England) 2005;19(6):630-2.
2005: Jean-Michel Molina; Anne-Geneviève Marcelin; Juliette Pavie; Laurence Heripret; Corinne Merle De Boever; Martine Troccaz; Ghislaine Leleu; Vincent Calvez
Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.
The Journal of infectious diseases 2005;191(6):840-7.
2005: N Alatrakchi; Claudine Duvivier; Dominique Costagliola; Assia Samri; Anne-Geneviève Marcelin; G Kamkamidze; M Astriti; Rachid Agher; Vincent Calvez; Brigitte Autran; Christine Katlama
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication.
AIDS (London, England) 2005;19(1):25-33.
2005: Philippe Flandre; Anne-Geneviève Marcelin; Juliette Pavie; Nathalie Shmidely; Marc Wirden; Olivier Lada; Marie-Charlotte Bernard; Jean-Michel Molina; Vincent Calvez
Comparison of tests and procedures to build clinically relevant genotypic scores: application to the Jaguar study.
Antiviral therapy 2005;10(4):479-87.
2004: Anne-Geneviève Marcelin; Cécile Dalban; Gilles Peytavin; Claire Lamotte; Rachid Agher; Constance Delaugerre; Marc Wirden; Françoise Conan; Sylvie Dantin; Christine Katlama; Dominique Costagliola; Vincent Calvez
Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2004;48(12):4687-92.
2004: Vincent Calvez
[Therapeutic strategies for HIV infection: virology approach].
Médecine et maladies infectieuses 2004;34 Suppl 3():S193-8.
2004: Jean Gabarre; Anne-Geneviève Marcelin; Nabih Azar; Sylvain Choquet; Vincent Lévy; Yves Lévy; Roland Tubiana; Frédéric Charlotte; Françoise Norol; Vincent Calvez; Michele Spina; Jean-Paul Vernant; Brigitte Autran; Véronique Leblond
High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
Haematologica 2004;89(9):1100-8.
2004: Philippe Bossi; Gilles Peytavin; Hocine Ait Mohand; Constance Delaugerre; Nadine Ktorza; Luc Paris; Manuela Bonmarchand; R Cacace; D-J David; Anne Simon; Claire Lamotte; Anne-Geneviève Marcelin; Vincent Calvez; François Bricaire; Dominique Costagliola; Christine Katlama
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
HIV medicine 2004;5(5):352-9.
2004: Anne-Geneviève Marcelin; Dissou Affolabi; Claire Lamotte; Hocine Ait Mohand; Constance Delaugerre; Marc Wirden; Delphine Voujon; Philippe Bossi; Nadine Ktorza; François Bricaire; Dominique Costagliola; Christine Katlama; Gilles Peytavin; Vincent Calvez
Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients.
Journal of medical virology 2004;74(1):16-20.
2004: Françoise Brun-Vézinet; Dominique Costagliola; Mounir Ait Khaled; Vincent Calvez; François Clavel; Bonaventura Clotet; Richard Haubrich; Dale J Kempf; Marty King; Daniel R Kuritzkes; Randall Lanier; M Miller; Veronica Miller; Andrews Phillips; Deenan Pillay; Jonathan M Schapiro; Janna Scott; Robert Shafer; Maurizio Zazzi; Andrew R Zolopa; Victor DeGruttola
Clinically validated genotype analysis: guiding principles and statistical concerns.
Antiviral therapy 2004;9(4):465-78.
2004: Christophe Piketty; Laurence Gérard; Corine Chazallon; Vincent Calvez; François Clavel; Anne-Marie Taburet; Pierre-Marie Girard; Jean-Pierre Aboulker
Virological and immunological impact of non-nucleoside reverse transcriptase inhibitor withdrawal in HIV-infected patients with multiple treatment failures.
AIDS (London, England) 2004;18(10):1469-71.
2004: Anne-Geneviève Marcelin; Isabelle Gorin; Patrice Morand; Zaina Ait-Arkoub; Jean Deleuze; Jean-Pierre Morini; Vincent Calvez; Nicolas Dupin
Quantification of Kaposi's sarcoma-associated herpesvirus in blood, oral mucosa, and saliva in patients with Kaposi's sarcoma.
AIDS research and human retroviruses 2004;20(7):704-8.
2004: Marc Wirden; Anne-Geneviève Marcelin; Roland Tubiana; Marc-Antoine Valantin; Jade Ghosn; Claudine Duvivier; Stephanie Dominguez; Luc Paris; Rachid Agher; Gilles Peytavin; Christine Katlama; Vincent Calvez
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level.
Journal of acquired immune deficiency syndromes (1999) 2004;36(3):876-8.
2004: Anne-Geneviève Marcelin; Jacques Reynes; Sabine Yerly; Nadine Ktorza; MICHEL SEGONDY; Jean-Claude Piot; Jean-François Delfraissy; Laurent Kaiser; Luc Perrin; Christine Katlama; Vincent Calvez
Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.
AIDS (London, England) 2004;18(9):1340-2.
2004: Christine Katlama; Jade Ghosn; Roland Tubiana; Marc Wirden; Marc-Antoine Valantin; Johan Harmenberg; Göran Mårdh; Bo Oberg; Vincent Calvez
MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study.
AIDS (London, England) 2004;18(9):1299-304.
2004: Constance Delaugerre; Laurence Morand-Joubert; Marie-Laure Chaix; Odile Picard; Anne-Geneviève Marcelin; Véronique Schneider; Anne Krivine; Alexandra Compagnucci; Christine Katlama; Pierre-Marie Girard; Vincent Calvez
Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
Antiviral therapy 2004;9(3):415-21.
2004: Anne-Marie Taburet; Christophe Piketty; Corine Chazallon; Isabelle Vincent; Laurence Gérard; Vincent Calvez; François Clavel; Jean-Pierre Aboulker; Pierre-Marie Girard
Interactions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2004;48(6):2091-6.
2004: Anne-Geneviève Marcelin; Anne-Marie Roque-Afonso; Monika Hurtova; Nicolas Dupin; Micheline Tulliez; Mylène Sebagh; Zaïna Aït Arkoub; Catherine Guettier; Didier Samuel; Vincent Calvez; Elisabeth Dussaix
Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004;10(2):295-300.
2004: Marc Wirden; Constance Delaugerre; Anne-Geneviève Marcelin; Nadine Ktorza; Hocine Ait Mohand; Stephanie Dominguez; Luminita Schneider; Jade Ghosn; Michele Pauchard; Dominique Costagliola; Christine Katlama; Vincent Calvez
Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.
Antimicrobial agents and chemotherapy 2004;48(2):644-7.
2004: Christine Katlama; Stephanie Dominguez; Karine Gourlain; Claudine Duvivier; Constance Delaugerre; Mayeule Legrand; Roland Tubiana; Jacques Reynes; Jean-Michel Molina; Gilles Peytavin; Vincent Calvez; Dominique Costagliola
Benefit of treatment interruption in HIV-infected patients with multiple therapeutic failures: a randomized controlled trial (ANRS 097).
AIDS (London, England) 2004;18(2):217-26.
2004: Anne-Geneviève Marcelin; Constance Delaugerre; Marc Wirden; Pedro Viegas; Anne Simon; Christine Katlama; Vincent Calvez
Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure.
Journal of medical virology 2004;72(1):162-5.
2003: Claudine Duvivier; Astriti Myrto; Anne-Geneviève Marcelin; Jade Ghosn; Hocine Ait Mohand; Luminita Schneider; Rachid Agher; François Bricaire; Dominique Costagliola; Vincent Calvez; Gilles Peytavin; Christine Katlama
Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.
Antiviral therapy 2003;8(6):603-9.
2003: Anne-Geneviève Marcelin; Laurent Aaron; Christine Mateus; Emmanuel Gyan; Isabelle Gorin; Jean-Paul Viard; Vincent Calvez; Nicolas Dupin
Rituximab therapy for HIV-associated Castleman disease.
Blood 2003;102(8):2786-8.
2003: Serge Perrot; Vincent Calvez; Jean-Paul Escande; Nicolas Dupin; Anne-Geneviève Marcelin
Prevalences of herpesviruses DNA sequences in salivary gland biopsies from primary and secondary Sjögren's syndrome using degenerated consensus PCR primers.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;28(2):165-8.
2003: Françoise Brun-Vézinet; Diane Descamps; Annick Ruffault; Bernard Masquelier; Vincent Calvez; Gilles Peytavin; Fabienne Telles; Laurence Morand-Joubert; Jean-Luc Meynard; Muriel Vray; Dominique Costagliola
Clinically relevant interpretation of genotype for resistance to abacavir.
AIDS (London, England) 2003;17(12):1795-802.
2003: Karine Gourlain; Bahia Amellal; Zaina Ait-Arkoub; Nicolas Dupin; Christine Katlama; Vincent Calvez
Quantitative analysis of human mitochondrial DNA using a real-time PCR assay.
HIV medicine 2003;4(3):287-92.
2003: Zaïna Ait-Arkoub; Catherine Robert-Visse; Vincent Calvez; Dominique Costagliola; Brigitte Autran; Daniel Candotti; Henri Agut
No influence of human herpesvirus 8 infection on the progression of HIV-1 infection in initially asymptomatic patients.
AIDS (London, England) 2003;17(9):1394-6.
2003: Constance Delaugerre; Karine Gourlain; Roland Tubiana; Guislaine Carcelain; Anne-Geneviève Marcelin; Cécile Chouquet; Mireille Mouroux; Claudine Duvivier; Brigitte Autran; Dominique Costagliola; Christine Katlama; Vincent Calvez
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Antiviral therapy 2003;8(3):233-7.
2003: Marc Wirden; Anne Simon; Luminita Schneider; Roland Tubiana; Luc Paris; Anne-Geneviève Marcelin; Constance Delaugerre; Mayeule Legrand; Serge Herson; Gilles Peytavin; Christine Katlama; Vincent Calvez
Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs.
Journal of clinical microbiology 2003;41(6):2713-5.
2003: I Kousignian; Brigitte Autran; Cécile Chouquet; Vincent Calvez; Elisabeth Gomard; Christine Katlama; Yves Rivière; Dominique Costagliola
Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients.
Statistics in medicine 2003;22(10):1675-90.
2003: Philippe Bossi; Gilles Peytavin; Claire Lamotte; Vincent Calvez; François Bricaire; Dominique Costagliola; Christine Katlama
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors.
AIDS (London, England) 2003;17(7):1108-10.
2003: Anne-Geneviève Marcelin; Claire Lamotte; Constance Delaugerre; Nadine Ktorza; Hocine Ait Mohand; Raquel Cacace; Manuela Bonmarchand; Marc Wirden; Anne Simon; Philippe Bossi; François Bricaire; Dominique Costagliola; Christine Katlama; Gilles Peytavin; Vincent Calvez
Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients.
Antimicrobial agents and chemotherapy 2003;47(2):594-600.
2003: Jade Ghosn; Claire Lamotte; Hocine Ait Mohand; Marc Wirden; Rachid Agher; Luminita Schneider; François Bricaire; Claudine Duvivier; Vincent Calvez; Gilles Peytavin; Christine Katlama
Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients.
AIDS (London, England) 2003;17(2):209-14.
2003: Philippe Bossi; Ollivier Legrand; Anne-Marie Faussat; Mayeule Legrand; François Bricaire; Jean-Pierre Marie; Henri Agut; B Diquet; Christine Katlama; Jean-Marie Huraux; Vincent Calvez
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors.
HIV medicine 2003;4(1):67-71.
2002: Nicolas Dupin; Marc Buffet; Anne-Geneviève Marcelin; Claire Lamotte; Isabelle Gorin; Zaina Ait-Arkoub; Jean-Marc Tréluyer; Patrick Bui; Vincent Calvez; Gilles Peytavin
HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophy.
AIDS (London, England) 2002;16(18):2419-24.
2002: Cécile Chouquet; Brigitte Autran; Elisabeth Gomard; Jean-Marc Bouley; Vincent Calvez; Christine Katlama; Dominique Costagliola; Yves Rivière
Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection.
AIDS (London, England) 2002;16(18):2399-407.
2002: Jas Gill; Dimitra Bourboulia; John Wilkinson; Peter Hayes; Alethea Cope; Anne-Geneviève Marcelin; Vincent Calvez; Frances Gotch; Chris Boshoff; Brian Gazzard
Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.
Journal of acquired immune deficiency syndromes (1999) 2002;31(4):384-90.
2002: Christine Katlama; Guislaine Carcelain; Claudine Duvivier; Cécile Chouquet; Roland Tubiana; Marcio De-Sa; Liliane Zagury; Vincent Calvez; Brigitte Autran; Dominique Costagliola
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.
AIDS (London, England) 2002;16(15):2027-34.
2002: Pierre Tattevin; Frédéric Davi; Hélène Merle-Béral; Vincent Calvez; Olivier Hermine; Thomas Papo
Chronic lymphocytic lymphoma and multiple myeloma in a patient infected with human herpesvirus 8 (HHV-8).
American journal of hematology 2002;71(2):138-9.
2002: Anne-Geneviève Marcelin; Marc Grandadam; Philippe Flandre; Elisabeth Nicand; Catherine Milliancourt; Jean-Louis Koeck; Michel Philippon; Remy Teyssou; Henri Agut; Nicolas Dupin; Vincent Calvez
Kaposi's sarcoma herpesvirus and HIV-1 seroprevalences in prostitutes in Djibouti.
Journal of medical virology 2002;68(2):164-7.
2002: Vincent Calvez; Dominique Costagliola; Diane Descamps; Anne Yvon; Gilles Collin; Agnès Cécile; Constance Delaugerre; Florence Damond; Anne-Geneviève Marcelin; Sophie Matheron; Anne Simon; Marc-Antoine Valantin; Christine Katlama; Françoise Brun-Vézinet
Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial.
Antiviral therapy 2002;7(3):211-8.
2002: Jean-Philippe Emond; Anne-Geneviève Marcelin; Richard Dorent; Catherine Milliancourt; Nicolas Dupin; Camille Frances; Henri Agut; Iradj Gandjbakhch; Vincent Calvez
Kaposi's sarcoma associated with previous human herpesvirus 8 infection in heart transplant recipients.
Journal of clinical microbiology 2002;40(6):2217-9.
2002: Constance Delaugerre; Anne-Geneviève Marcelin; Vincent Thibault; Gilles Peytavin; Tony Bombled; Marie Bochet; Christine Katlama; Yves Benhamou; Vincent Calvez
Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine.
Antimicrobial agents and chemotherapy 2002;46(5):1586-8.
2002: Philippe Flandre; François Raffi; Diane Descamps; Vincent Calvez; Gilles Peytavin; Vincent Meiffredy; Marine Harel; Sylvie Hazebrouck; Gilles Pialoux; Jean-Pierre Aboulker; Françoise Brun Vezinet
Final analysis of the Trilège induction-maintenance trial: results at 18 months.
AIDS (London, England) 2002;16(4):561-8.
2002: John Wilkinson; Alethea Cope; Jas Gill; Dimitra Bourboulia; Peter Hayes; Nesrina Imami; Toru Kubo; Anne-Geneviève Marcelin; Vincent Calvez; Robin Weiss; Brian Gazzard; Chris Boshoff; Frances Gotch
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.
Journal of virology 2002;76(6):2634-40.
2002: Vincent Thibault; Constance Delaugerre; Vincent Calvez; Dominique Costagliola; Roland Tubiana; Christine Katlama
Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial.
Hepatology (Baltimore, Md.) 2002;35(1):238-9.
2001: Anne-Geneviève Marcelin; Catherine Milliancourt; Nicolas Dupin; Marc Wirden; Jean-Marie Huraux; Henri Agut; Vincent Calvez
Effects of cyclosporine and hydrocortisone on Kaposi's sarcoma-associated herpesvirus genome replication and cell apoptosis induction.
Transplantation 2001;72(10):1700-3.
2001: Constance Delaugerre; Marc-Antoine Valantin; Mireille Mouroux; Manuela Bonmarchand; Guislaine Carcelain; Claudine Duvivier; Roland Tubiana; Anne Simon; François Bricaire; Henri Agut; Brigitte Autran; Christine Katlama; Vincent Calvez
Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.
AIDS (London, England) 2001;15(16):2189-91.
2001: Constance Delaugerre; R Rohban; Anne Simon; Mireille Mouroux; C Tricot; Rachid Agher; Jean-Marie Huraux; Christine Katlama; Vincent Calvez
Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.
Journal of medical virology 2001;65(3):445-8.
2001: Catherine Milliancourt; Stéphane Barete; Anne-Geneviève Marcelin; Catherine Mouquet; Nicolas Dupin; Camille Francès; Henri Agut; Marc-Olivier Bitker; Vincent Calvez
Human herpesvirus-8 seroconversions after renal transplantation.
Transplantation 2001;72(7):1319-20.
2001: Vincent Calvez; A G Marcelin; H Agut; N Dupin
[Pathogenic and epidemiologic power of human herpesvirus 8 infections].
Annales de biologie clinique 2001;59 Spec No():37-45.
2001: Diane Descamps; Vincent Calvez; Jacques Izopet; Claudine Buffet-Janvresse; Anne Schmuck; Philippe Colson; Annick Ruffault; A Maillard; Bernard Masquelier; Jacqueline Cottalorda; Martine Harzic; Françoise Brun-Vézinet; Dominique Costagliola
Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.
AIDS (London, England) 2001;15(14):1777-82.
2001: Mireille Mouroux; Diane Descamps; Jacques Izopet; Anne Yvon; Constance Delaugerre; Sophie Matheron; A Coutellier; Marc-Antoine Valantin; Manuela Bonmarchand; Henri Agut; P Massip; Dominique Costagliola; Christine Katlama; Françoise Brun Vezinet; Vincent Calvez
Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.
Antiviral therapy 2001;6(3):179-83.
2001: M K Singh; Geneviève Janvier; Vincent Calvez; P Coulaud; Yves Rivière
A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
AIDS research and human retroviruses 2001;17(13):1265-71.
2001: Yves Benhamou; Marie Bochet; Vincent Thibault; Vincent Calvez; Marie-Hélène Fievet; P Vig; Craig S Gibbs; Carol L Brosgart; John Fry; Hamid Namini; Christine Katlama; Thierry Poynard
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study.
Lancet 2001;358(9283):718-23.
2001: A Yvon-Groussin; P Mugnier; P Bertin; Marc Grandadam; Henri Agut; Jean-Marie Huraux; Vincent Calvez
Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure.
Journal of virology 2001;75(15):7184-7.
2001: Bernard Masquelier; Ester Race; Catherine Tamalet; Diane Descamps; Jacques Izopet; Claudine Buffet-Janvresse; Annick Ruffault; A S Mohammed; Jacqueline Cottalorda; Anne Schmuck; Vincent Calvez; Elisabeth DAM; H Fleury; Françoise Brun-Vézinet
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors.
Antimicrobial agents and chemotherapy 2001;45(6):1836-42.
2001: P Bossi; R Tubiana; Vincent Calvez; G Peytavin; C Katlama; F Bricaire
[Management of therapeutic failure in HIV-infected patients].
Presse médicale (Paris, France : 1983) 2001;30(16):806-12.
2001: Constance Delaugerre; Mireille Mouroux; A Yvon-Groussin; Anne Simon; F Angleraud; Jean-Marie Huraux; Henri Agut; Christine Katlama; Vincent Calvez
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.
Antimicrobial agents and chemotherapy 2001;45(3):946-8.
2001: Bruno Stankoff; Ayman Tourbah; SV Suarez; E Turell; Jean-Louis Stievenart; Christine Payan; A Coutellier; Serge Herson; L Baril; François Bricaire; Vincent Calvez; Emmanuel Alain Cabanis; Lucette Lacomblez; Catherine Lubetzki
Clinical and spectroscopic improvement in HIV-associated cognitive impairment.
Neurology 2001;56(1):112-5.
2001: Christine Katlama; J L Pellegrin; D Lacoste; C Aquilina; F Raffi; G Pialoux; D Vittecoq; G Raguin; Olivier Lantz; Mireille Mouroux; Vincent Calvez; A Trylesinski; F Montestruc; E Dohin; J M Goehrs; Jean-François Delfraissy
MIKADO: a multicentre, open-label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine.
HIV medicine 2001;2(1):20-6.
2001: Guislaine Carcelain; Roland Tubiana; Assia Samri; Vincent Calvez; Constance Delaugerre; H Agut; Christine Katlama; Brigitte Autran
Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.
Journal of virology 2001;75(1):234-41.
2000: Marianne Burgard; Jacques Izopet; B Dumon; Catherine Tamalet; Diane Descamps; Annick Ruffault; A Vabret; G Bargues; Mireille Mouroux; Isabelle Pellegrin; S Ivanoff; O Guisthau; Vincent Calvez; Jean-Marie Seigneurin; Christine Rouzioux
HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.
AIDS research and human retroviruses 2000;16(18):1939-47.
2000: B Combadère; C Blanc; T Li; Guislaine Carcelain; Constance Delaugerre; Vincent Calvez; Roland Tubiana; Patrice Debré; Christine Katlama; Brigitte Autran
CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle.
European journal of immunology 2000;30(12):3598-603.
2000: Stéphane Barete; Vincent Calvez; Catherine Mouquet; Benoît Barrou; H Kreis; J Dantal; Richard Dorent; F Durand; Y Dimitrov; Nicolas Dupin; Anne-Geneviève Marcelin; Jean-Charles Piette; Marc-Olivier Bitker; Camille Francès
Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients.
Archives of dermatology 2000;136(12):1452-8.
2000: Assia Samri; Gaby Haas; J Duntze; Jean-Marc Bouley; Vincent Calvez; Christine Katlama; Brigitte Autran
Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells.
Journal of virology 2000;74(19):9306-12.
2000: L Mollet; T S Li; Assia Samri; C Tournay; Roland Tubiana; Vincent Calvez; Patrice Debré; Christine Katlama; Brigitte Autran
Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1692-704.
2000: Mireille Mouroux; A Yvon-Groussin; Gilles Peytavin; Constance Delaugerre; Mayeule Legrand; Philippe Bossi; B Do; A Trylesinski; B Diquet; E Dohin; Jean-François Delfraissy; Christine Katlama; Vincent Calvez
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance.
Journal of clinical microbiology 2000;38(7):2726-30.
2000: Mireille Mouroux; Jacques Izopet; Diane Descamps; Constance Delaugerre; A Yvon-Groussin; F Angleraud; A Coutellier; Manuela Bonmarchand; Marc-Antoine Valantin; Sophie Matheron; Henri Agut; Christine Katlama; Françoise Brun Vezinet; Vincent Calvez
[Conditions of "thymidine analog mutations" (TAMs) in naive patients treated with different combinations of d4T].
Pathologie-biologie 2000;48(5):508-12.
2000: Camille Francès; Catherine Mouquet; Anne-Geneviève Marcelin; Stéphane Barete; Rachid Agher; D Charron; Hadjira Benalia; Nicolas Dupin; Jean-Charles Piette; Marc-Olivier Bitker; Vincent Calvez
Outcome of kidney transplant recipients with previous human herpesvirus-8 infection.
Transplantation 2000;69(9):1776-9.
2000: Nicolas Dupin; Vincent Calvez
[HHV-8/KSHV. I - epidemiological and molecular aspects].
Annales de dermatologie et de vénéréologie 2000;127(5):528-31.
2000: Nicolas Dupin; Anne-Geneviève Marcelin; Eric Caumes; Stéphane Barete; Zaïna Aït Arkoub; Philippe Bossi; Rachid Agher; Vincent Calvez
Relationship between Kaposi's sarcoma, Kaposi's sarcoma-associated herpesvirus and AIDS dementia complex.
AIDS (London, England) 2000;14(3):333-5.
2000: Diane Descamps; Philippe Flandre; Vincent Calvez; Gilles Peytavin; Vincent Meiffredy; Gilles Collin; Constance Delaugerre; S Robert-Delmas; B Bazin; Jean-Pierre Aboulker; Gilles Pialoux; François Raffi; Françoise Brun-Vézinet
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
JAMA : the journal of the American Medical Association 2000;283(2):205-11.
1999: Vincent Calvez; S Barete; Nicolas Dupin
[Human herpesvirus 8 (HHV-8)].
La Revue du praticien 1999;49(20):2232-6.
1999: Bruno Stankoff; Vincent Calvez; SV Suarez; Philippe Bossi; O Rosenblum; L Conquy; E Turell; T Dubard; A Coutellier; L Baril; François Bricaire; Lucette Lacomblez; Catherine Lubetzki
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment.
European journal of neurology : the official journal of the European Federation of Neurological Societies 1999;6(6):669-75.
1999: Patrice Cacoub; Pascale Ghillani; R Revelen; Vincent Thibault; Vincent Calvez; Frédéric Charlotte; Lucile Musset; P Youinou; Jean-Charles Piette
Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.
Journal of hepatology 1999;31(4):598-603.
1999: Philippe Bossi; Mireille Mouroux; Anne Yvon; François Bricaire; Henri Agut; Jean-Marie Huraux; Christine Katlama; Vincent Calvez
Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor.
Journal of clinical microbiology 1999;37(9):2910-2.
1999: D Candotti; Vincent Calvez; B Autran; D Costagliola; C Rouzioux; Henri Agut
Decreased peripheral circulation of HIV-infected cells in a subset of long-term nonprogressors. The French ALT Study Group.
Journal of acquired immune deficiency syndromes (1999) 1999;21(3):253-5.
1999: Nicolas Dupin; Anne-Geneviève Marcelin; Vincent Calvez; C Andr
Absence of a link between human herpesvirus 8 and pemphigus.
The British journal of dermatology 1999;141(1):159-60.
1999: F Grassi; Anne Hosmalin; Dorian McIlroy; Vincent Calvez; Patrice Debré; Brigitte Autran
Depletion in blood CD11c-positive dendritic cells from HIV-infected patients.
AIDS (London, England) 1999;13(7):759-66.
1999: Mireille Mouroux; Philippe Bossi; A Yvon-Groussin; Constance Delaugerre; Marc-Antoine Valantin; Roland Tubiana; A Coutellier; Manuela Bonmarchand; François Bricaire; Christine Katlama; Henri Agut; Jean-Marie Huraux; Vincent Calvez
[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].
Pathologie-biologie 1999;47(5):549-52.
1999: Nicolas Dupin; V Rubin De Cervens; Isabelle Gorin; Vincent Calvez; E Pessis; Marc Grandadam; Claire Rabian; Jean-Paul Viard; Jean-Marie Huraux; Jean-Paul Escande
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
The British journal of dermatology 1999;140(5):875-81.
1999: A U Neumann; Roland Tubiana; Vincent Calvez; C Robert; T S Li; H Agut; Brigitte Autran; Christine Katlama
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.
AIDS (London, England) 1999;13(6):677-83.
1999: M Renaud; Christine Katlama; A Mallet; Vincent Calvez; Guislaine Carcelain; Roland Tubiana; Marc Jouan; Eric Caumes; Henri Agut; François Bricaire; Patrice Debré; Brigitte Autran
Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen.
AIDS (London, England) 1999;13(6):669-76.
1999: Camille Francès; Catherine Mouquet; Vincent Calvez
Human herpesvirus 8 and renal transplantation.
The New England journal of medicine 1999;340(13):1045; author reply 1046.
1999: Brigitte Autran; G Carcelaint; TS Li; Guy Gorochov; C Blanc; M Renaud; M Durali; Dominique Mathez; Vincent Calvez; Jacques Leibowitch; Christine Katlama; Patrice Debré
Restoration of the immune system with anti-retroviral therapy.
Immunology letters 1999;66(1-3):207-11.
1999: T Papo; M Soubrier; Anne-Geneviève Marcelin; Vincent Calvez; B Wechsler; Jean-Marie Huraux; J C Piette; P Cacoub
Human herpesvirus 8 infection, Castleman's disease and POEMS syndrome.
British journal of haematology 1999;104(4):932-3.
1999: Roland Tubiana; Guislaine Carcelain; Hocine Ait Mohand; TS Li; M Renaud; C Blanc; Vincent Calvez; Patrice Debré; Henri Agut; Christine Katlama; Brigitte Autran; François Bricaire
[Immunologic reconstruction after antiretroviral treatment].
Presse médicale (Paris, France : 1983) 1999;28(8):424-8.
1999: Guislaine Carcelain; TS Li; M Renaud; C Blanc; Roland Tubiana; Vincent Calvez; Jacques Leibowitch; Patrice Debré; Henri Agut; Christine Katlama; Brigitte Autran
[Antiretroviral therapy and immune reconstitution].
Journal de la Société de biologie 1999;193(1):5-10.
1999: Jean-Marie Huraux; Anne-Marie Fillet; Vincent Calvez; H Blanchier; C Huraux-Rendu
[Maternal-fetal viral infections: preventive treatment of maternal-fetal transmission during pregnancy, delivery and after birth].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 1999;6 Suppl 2():411s-413s.
1998: Anne-Geneviève Marcelin; Cristian Apetrei; Nicolas Dupin; Philippe Bossi; Diane Descamps; François SIMON; Vincent Calvez
Parenteral transmission of Kaposi's sarcoma-associated herpesvirus.
AIDS (London, England) 1998;12(17):2351.
1998: Bruno Stankoff; SV Suarez; O Rosemblum; L Conquy; E Turell; François Bricaire; A Coutellier; Vincent Calvez; Lucette Lacomblez; Ayman Tourbah; Catherine Lubetzki
[Cognitive disorders in AIDS: clinical, virological and neuroradiological features].
Revue neurologique 1998;154(12):843-9.
1998: Philippe Bossi; Vincent Calvez; François Bricaire
[Resistance to antiretroviral agents: mechanism and study methods].
Presse médicale (Paris, France : 1983) 1998;27 Suppl 5():18-9.
1998: Vincent Calvez; Philippe Bossi
[HHV-8 related diseases].
Presse médicale (Paris, France : 1983) 1998;27 Suppl 5():16.
1998: Philippe Bossi; Anne Yvon; Mireille Mouroux; Jean-Marie Huraux; Henri Agut; Vincent Calvez
Mutations in the human immunodeficiency virus type 1 reverse transcriptase gene observed in stavudine and didanosine strains obtained by in vitro passages.
Research in virology 1998;149(6):355-61.
1998: Didier Bouscary; N Dupin; Serge Fichelson; Marc Grandadam; Michaëla Fontenay-Roupie; Anne-Geneviève Marcelin; P Blanche; Françoise Picard; JM Freyssinier; P Ravaud; François Dreyfus; Vincent Calvez
Lack of evidence of an association between HHV-8 and multiple myeloma.
Leukemia 1998;12(11):1840-1.
1998: Christine Katlama; Marc-Antoine Valantin; Sophie Matheron; A Coutellier; Vincent Calvez; Diane Descamps; C Longuet; Manuela Bonmarchand; Roland Tubiana; Marcio De-Sa; R Lancar; Henri Agut; Françoise Brun Vezinet; Dominique Costagliola
Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.
Annals of internal medicine 1998;129(7):525-31.
1998: Marina Karmochkine; A Ankri; Vincent Calvez; M Bonmarchant; A Coutellier; S Herson
Plasma hypercoagulability is correlated to plasma HIV load.
Thrombosis and haemostasis 1998;80(1):208-9.
1998: Diane Descamps; Vincent Calvez; Gilles Collin; A Cécille; Cristian Apetrei; Florence Damond; C Katlama; Sophie Matheron; J M Huraux; Françoise Brun-Vézinet
Line probe assay for detection of human immunodeficiency virus type 1 mutations conferring resistance to nucleoside inhibitors of reverse transcriptase: comparison with sequence analysis.
Journal of clinical microbiology 1998;36(7):2143-5.
1998: T S Li; Roland Tubiana; Christine Katlama; Vincent Calvez; Hocine Ait Mohand; Brigitte Autran
Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease.
Lancet 1998;351(9117):1682-6.
1998: Philippe Bossi; S Dupré; N Dupin; A Coutellier; François Bricaire; Catherine Lubetzki; Christine Katlama; Vincent Calvez
[Clinical importance of the quantification of HIV-1 RNA in cerebrospinal fluid for the diagnosis of HIV encephalitis].
Pathologie-biologie 1998;46(6):423-5.
1998: Nicolas Dupin; Anne-Geneviève Marcelin; Isabelle Gorin; P Bossi; Nathalie Franck; Bernard Weill; Jean-Marie Huraux; Jean-Paul Escande; Vincent Calvez
Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases.
Archives of dermatology 1998;134(6):700-2.
1998: Philippe Bossi; N Dupin; A Coutellier; François Bricaire; Catherine Lubetzki; Christine Katlama; Vincent Calvez
The level of human immunodeficiency virus (HIV) type 1 RNA in cerebrospinal fluid as a marker of HIV encephalitis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(5):1072-3.
1998: Marina Karmochkine; Christophe Parizot; Vincent Calvez; A Coutellier; Serge Herson; Patrice Debré; Guy Gorochov
Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17(5):419-23.
1998: Anne-Geneviève Marcelin; Nicolas Dupin; Philippe Bossi; Vincent Calvez
Seroprevalence of human herpesvirus-8 in healthy subjects and patients with AIDS-associated and classical Kaposi's sarcoma in France.
AIDS (London, England) 1998;12(5):539-40.
1998: L Mollet; B Sadat-Sowti; J Duntze; Véronique Leblond; F Bergeron; Vincent Calvez; Christine Katlama; Patrice Debré; Brigitte Autran
CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.
International immunology 1998;10(3):311-23.
1998: Georges Mansour; Frédéric Charlotte; Vincent Calvez; Frédéric Davi; Hélène Merle-Béral
AIDS-related primary lymphoma of the pleural cavity. A case report.
Acta cytologica 1998;42(2):371-3.
1998: Vincent Calvez
Resistance to antiretroviral drugs.
Antiviral therapy 1998;3 Suppl 4():5-7.
1997: Anne-Geneviève Marcelin; Nicolas Dupin; Didier Bouscary; Philippe Bossi; P Cacoub; P Ravaud; Vincent Calvez
HHV-8 and multiple myeloma in France.
Lancet 1997;350(9085):1144.
1997: Nicolas Dupin; Anne Krivine; Vincent Calvez; Isabelle Gorin; Nathalie Franck; Jean-Paul Escande
No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient.
AIDS (London, England) 1997;11(11):1400-1.
1997: Jean-Marie Huraux; L Moutouh; Vincent Calvez; Nicolas Dupin
[The 8th human herpesvirus].
Presse médicale (Paris, France : 1983) 1997;26(22):1058-62.
1997: Henri Agut; Vincent Calvez; Anne-Marie Fillet; Jean-Marie Huraux
[The discovery of three novel human viruses, human herpesviruses 6, 7, and 8].
Bulletin de l'Académie nationale de médecine 1997;181(6):1009-22.
1997: Nicolas Dupin; Nathalie Franck; Vincent Calvez; Isabelle Gorin; Marc Grandadam; Jean-Marie Huraux; M Leibowitch; H Agut; Jean-Paul Escande
Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with various lymphoproliferative disorders of the skin.
The British journal of dermatology 1997;136(6):827-30.
1997: Marc Grandadam; N Dupin; Vincent Calvez; Isabelle Gorin; L Blum; S Kernbaum; Didier Sicard; Yves Buisson; H Agut; Jean-Paul Escande; Jean-Marie Huraux
Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.
The Journal of infectious diseases 1997;175(5):1198-201.
1997: N Dupin; Isabelle Gorin; Jean-Paul Escande; Vincent Calvez; Marc Grandadam; Jean-Marie Huraux; H Agut
Lack of evidence of any association between human herpesvirus 8 and various skin tumors from both immunocompetent and immunosuppressed patients.
Archives of dermatology 1997;133(4):537.
1997: L Moutouh; Vincent Calvez; Jean-Marie Huraux
[The future of antiviral drugs].
La Revue du praticien 1997;47(6):652-7.
1997: Henri Agut; Anne-Marie Fillet; Vincent Calvez
[What is a virus?].
La Revue du praticien 1997;47(6):602-7.
1996: Nicolas Dupin; S Perrot; Vincent Calvez; Isabelle Gorin; Marc Grandadam; H Agut; Jean-Paul Escande; C J Menkès
Detection of HHV-8 in Sjögren's syndrome.
The American journal of medicine 1996;101(6):657-8.
1996: Vincent Calvez; Olivier Rixe; P Wang; Roger MOUAWAD; Claude Soubrane; Abdel M Ghoumari; O Verola; David Khayat; Florence Colbère-Garapin
Virus-free transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment induces tumor cell death.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(1):47-51.
1995: Nicolas Dupin; Marc Grandadam; Vincent Calvez; Isabelle Gorin; Jean-Thierry Aubin; S Havard; F Lamy; M Leibowitch; Jean-Marie Huraux; Jean-Paul Escande
Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.
Lancet 1995;345(8952):761-2.
1995: H Agut; Vincent Calvez
[New methods of quantification of the viral load in HIV infection].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(12):976-8.